Literature DB >> 7542578

Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

J A Rump1, D Jakschiess, U Walker, M Schlesier, P von Wussow, H H Peter.   

Abstract

The underlying immunopathogenic mechanism of CVID has been suspected to involve a chronic viral infection or an autoimmune condition. However, formal proof of viral infection is lacking. Measurement of MxA-protein in leucocyte lysates is a sensitive test for evaluating the activation of the host's interferon system. Both viral infections and autoimmune diseases such as systemic lupus erythematosus (SLE) strongly induce MxA-protein in peripheral leucocytes. We therefore examined 15 patients with longlasting hypogammaglobulinaemia for MxA-protein induction in vivo: 13 patients suffered from CVID, one from hyper-IgM syndrome, and one patient had chronic B lymphocytic leukaemia associated with immunoglobulin deficiency and chronic papilloma virus infection (condylomata accuminata). Only the latter patient exhibited a strong MxA-protein expression; two CVID patients were borderline positive, and the remaining 12 patients including the hyper-IgM syndrome were MxA-protein-negative. There was no relationship between MxA expression and low CD4/CD8 ratios or increased CD8/CD57+ T cell counts, although both conditions are often observed in CVID as well as in chronic viral infections. When exposed in vitro to interferon-alpha (IFN-alpha), peripheral blood leucocytes of four MxA-negative patients were capable of producing normal amounts of MxA-protein. Taken together, these results argue against a viral or autoimmune pathogenesis of CVID.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542578      PMCID: PMC1553315          DOI: 10.1111/j.1365-2249.1995.tb02282.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Cytomegalovirus infection and common variable immunodeficiency.

Authors:  W D Döcke; H U Simon; E Fietze; S Prösch; C Diener; P Reinke; H Stein; H D Volk
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

2.  Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency.

Authors:  J A Rump; A Jahreis; M Schlesier; R Dräger; I Melchers; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

3.  Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle.

Authors:  J Pavlovic; O Haller; P Staeheli
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Distribution and phenotypes of duodenal intraepithelial gamma/delta T cells in patients with various types of primary B-cell deficiency.

Authors:  D E Nilssen; T S Halstensen; S S Frøland; O Fausa; P Brandtzaeg
Journal:  Clin Immunol Immunopathol       Date:  1993-09

5.  Intestinal B cell defects in common variable immunodeficiency.

Authors:  E W Herbst; M Armbruster; J A Rump; H P Buscher; H H Peter
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency.

Authors:  M B Fischer; I Hauber; E Vogel; H M Wolf; J W Mannhalter; M M Eibl
Journal:  J Allergy Clin Immunol       Date:  1993-08       Impact factor: 10.793

8.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Lymphotropic viruses in 'common variable' immunodeficiency--PCR analysis of lymphocyte DNA for HIV-1 and HHV-6.

Authors:  A Sa'Adu; B J Thomson; L Bountiff; A D Webster
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation.

Authors:  E M Eisenstein; J S Jaffe; W Strober
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

View more
  2 in total

Review 1.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

2.  Pathogenesis of autoimmunity in common variable immunodeficiency.

Authors:  Klaus Warnatz; Reinhard E Voll
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.